Page 3 - ஒருங்கிணைந்த பாஸிடிவ் மதிப்பெண் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒருங்கிணைந்த பாஸிடிவ் மதிப்பெண். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒருங்கிணைந்த பாஸிடிவ் மதிப்பெண் Today - Breaking & Trending Today

Increasing R&D Studies to Develop Cancer Vaccines Attributed to Spike in Number of Cancer Patients


Increasing R&D Studies to Develop Cancer Vaccines Attributed to Spike in Number of Cancer Patients
- Financialnewsmedia.com News Commentary
Share this article
Share this article
PALM BEACH, Fla., Feb. 18, 2021 /PRNewswire/  Ovarian cancer and its rising incidence rate is a growing concern worldwide and the rising incidence of ovarian cancer will be driving the ovarian cancer drugs market for years to come. Ovarian cancer is regarded as one of the most common types of cancer among women. It accounts for more deaths than any other cancer of the female reproductive system, while it ranks 5th in overall women deaths due to cancer. This type of cancer is rarely diagnosed at an early stage, making treatment at an advanced stage difficult. According to American Cancer Society estimates, risk of any woman acquiring ovarian cancer in her lifetime is 1 in 75, while her chance of death due to ovarian cancer is 1 in 100. Ovarian cancer is more prevalent among elderly women, ....

United States , National Taiwan University Hospital , T Ai Pei , United Kingdom , Stevenm Fruchtman , Eden Biocell , Jonathan Zalevsky , Kenneth Kovan , Company Investigational New Drug , National Cancer Institute , Ovarian Cancer Vaccine Biovaxys Technology Corp , Biovaxys Technology , Evofem Biosciences Inc , Fn Media Group , Biovaxys Technology Corp , Procare Health Iberia , Procare Health , American Cancer Society , Epidemiology Program , Ziopharm Oncology Inc , Drug Administration , United States American Cancer Society Facts Figures , Health Products , Exchange Commission , Market Research , World Cancer Research Fund ,